Ironwood Pharmaceuticals (IRWD) Total Debt Growth (3y) (2016 - 2026)
Ironwood Pharmaceuticals (IRWD) Total Debt Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 92.83% |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | -13.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.70% |
| Mar 31, 2025 | 47.25% |
| Dec 31, 2024 | 48.80% |
| Sep 30, 2024 | 51.59% |
| Jun 30, 2024 | 55.58% |
| Mar 31, 2022 | 10.18% |
| Dec 31, 2021 | 5.12% |
| Sep 30, 2021 | 1.86% |
| Jun 30, 2021 | -2.84% |
| Jun 30, 2019 | -11.38% |
| Mar 31, 2019 | -10.25% |
| Dec 31, 2018 | -8.88% |
| Sep 30, 2018 | -8.49% |
| Jun 30, 2018 | -5.93% |
| Mar 31, 2018 | -5.01% |
| Dec 31, 2017 | -2.37% |
| Sep 30, 2017 | 14.15% |
| Jun 30, 2017 | -1.37% |
| Mar 31, 2017 | -1.94% |
| Dec 31, 2016 | -5.70% |